27 related articles for article (PubMed ID: 10223336)
1. Cell-permeable capsids as universal antigen carrier for the induction of an antigen-specific CD8
Akhras S; Toda M; Boller K; Himmelsbach K; Elgner F; Biehl M; Scheurer S; Gratz M; Vieths S; Hildt E
Sci Rep; 2017 Aug; 7(1):9630. PubMed ID: 28851900
[TBL] [Abstract][Full Text] [Related]
2. Influence of Brucella abortus lipopolysaccharide as an adjuvant on the immunogenicity of HPV-16 L1VLP vaccine in mice.
Kianmehr Z; Soleimanjahi H; Ardestani SK; Fotouhi F; Abdoli A
Med Microbiol Immunol; 2015 Apr; 204(2):205-13. PubMed ID: 25187406
[TBL] [Abstract][Full Text] [Related]
3. Developing vaccines against minor capsid antigen L2 to prevent papillomavirus infection.
Karanam B; Jagu S; Huh WK; Roden RB
Immunol Cell Biol; 2009; 87(4):287-99. PubMed ID: 19421199
[TBL] [Abstract][Full Text] [Related]
4. Human papillomavirus type 16 (HPV-16) virus-like particle L1-specific CD8+ cytotoxic T lymphocytes (CTLs) are equally effective as E7-specific CD8+ CTLs in killing autologous HPV-16-positive tumor cells in cervical cancer patients: implications for L1 dendritic cell-based therapeutic vaccines.
Bellone S; El-Sahwi K; Cocco E; Casagrande F; Cargnelutti M; Palmieri M; Bignotti E; Romani C; Silasi DA; Azodi M; Schwartz PE; Rutherford TJ; Pecorelli S; Santin AD
J Virol; 2009 Jul; 83(13):6779-89. PubMed ID: 19386711
[TBL] [Abstract][Full Text] [Related]
5. A direct comparison of human papillomavirus type 16 L1 particles reveals a lower immunogenicity of capsomeres than viruslike particles with respect to the induced antibody response.
Thönes N; Herreiner A; Schädlich L; Piuko K; Müller M
J Virol; 2008 Jun; 82(11):5472-85. PubMed ID: 18385253
[TBL] [Abstract][Full Text] [Related]
6. Comparison of cervical and blood T-cell responses to human papillomavirus-16 in women with human papillomavirus-associated cervical intraepithelial neoplasia.
Passmore JA; Milner M; Denny L; Sampson C; Marais DJ; Allan B; Gumbi PP; Hitzeroth II; Rybicki EP; Williamson AL
Immunology; 2006 Dec; 119(4):507-14. PubMed ID: 17026720
[TBL] [Abstract][Full Text] [Related]
7. Papillomavirus-like particles stimulate murine bone marrow-derived dendritic cells to produce alpha interferon and Th1 immune responses via MyD88.
Yang R; Murillo FM; Cui H; Blosser R; Uematsu S; Takeda K; Akira S; Viscidi RP; Roden RB
J Virol; 2004 Oct; 78(20):11152-60. PubMed ID: 15452235
[TBL] [Abstract][Full Text] [Related]
8. Priming of human papillomavirus type 11-specific humoral and cellular immune responses in college-aged women with a virus-like particle vaccine.
Emeny RT; Wheeler CM; Jansen KU; Hunt WC; Fu TM; Smith JF; MacMullen S; Esser MT; Paliard X
J Virol; 2002 Aug; 76(15):7832-42. PubMed ID: 12097595
[TBL] [Abstract][Full Text] [Related]
9. Prevention of cervical cancer with vaccines.
Im SS; Monk BJ; Villarreal LP
Curr Oncol Rep; 2001 Jul; 3(4):322-8. PubMed ID: 11389816
[TBL] [Abstract][Full Text] [Related]
10. Papillomavirus-like particle based vaccines: cervical cancer and beyond.
Schiller JT; Lowy DR
Expert Opin Biol Ther; 2001 Jul; 1(4):571-81. PubMed ID: 11727495
[TBL] [Abstract][Full Text] [Related]
11. Interaction of Viral Capsid-Derived Virus-Like Particles (VLPs) with the Innate Immune System.
Mohsen MO; Gomes AC; Vogel M; Bachmann MF
Vaccines (Basel); 2018 Jul; 6(3):. PubMed ID: 30004398
[TBL] [Abstract][Full Text] [Related]
12. Induction of HPV16 capsid protein-specific human T cell responses by virus-like particles.
Rudolf MP; Nieland JD; DaSilva DM; Velders MP; Müller M; Greenstone HL; Schiller JT; Kast WM
Biol Chem; 1999 Mar; 380(3):335-40. PubMed ID: 10223336
[TBL] [Abstract][Full Text] [Related]
13. Comparison of human papillomavirus type 16 L1 chimeric virus-like particles versus L1/L2 chimeric virus-like particles in tumor prevention.
Wakabayashi MT; Da Silva DM; Potkul RK; Kast WM
Intervirology; 2002; 45(4-6):300-7. PubMed ID: 12566713
[TBL] [Abstract][Full Text] [Related]
14. Human dendritic cells are activated by chimeric human papillomavirus type-16 virus-like particles and induce epitope-specific human T cell responses in vitro.
Rudolf MP; Fausch SC; Da Silva DM; Kast WM
J Immunol; 2001 May; 166(10):5917-24. PubMed ID: 11342606
[TBL] [Abstract][Full Text] [Related]
15. Chimeric papillomavirus virus-like particles elicit antitumor immunity against the E7 oncoprotein in an HPV16 tumor model.
Greenstone HL; Nieland JD; de Visser KE; De Bruijn ML; Kirnbauer R; Roden RB; Lowy DR; Kast WM; Schiller JT
Proc Natl Acad Sci U S A; 1998 Feb; 95(4):1800-5. PubMed ID: 9465097
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
